dihexa administration oral subcutaneous Dihexa (PNB-0408) Dihexa | 2.5mg | 60

Epub 2009 Mar 16

Research use only: what this article is, and what it isnt This article is a benchwork reference for researchers handling a co-formulated BPC-157 and TB-500 vial in vitro or in preclinical models

Conclusion Intravesical BPC-157 (10 mg) injection has shown remarkable effectiveness for patients with moderate to severe interstitial cystitis who have not responded to pentosan polysulfate

This is important because TNF-alpha is a driver of inflammation in IBD and a target of current therapeutics like infliximab (Remicade/Inflectra) and adalimumab (Humira)

Why injections use it: it is held on to well in the body, so injections can be spaced further apart

Hip Tendonitis Hip tendonitis is a common orthopedic condition characterized by inflammation or irritation of the tendons surrounding the hip joint